John Green v Johnson & Johnson: The Fault in Our Patents

When we learned that John Green, the beloved writer - and RUclips superstar ‪@vlogbrothers‬ - was rallying his online community around a fight over drug prices, we were pumped.
And this story took us in so many different directions: Literally around the world, and then straight back home.
The drug in question is bedaquiline, made by Johnson & Johnson. It treats drug-resistant tuberculosis, and its price has been a huge obstacle to getting it to places it’s needed most - primarily places far away from the U.S.
But the reason this TB drug costs so much overseas is also one of the main reasons that important drugs here are so expensive - drugs like insulin, Humira and… well, just about everything:
Legalistic patent games that pharma companies have mastered.
So, in addition to John Green - and yes, we talked with John Green - we also talked with one of the world’s leading experts on drug-patent games, Tahir Amin.
Oh, finally: This is, as you’re probably guessing by now, an epic story. It’s gonna take two full episodes of An Arm and a Leg to tell it all.
So, we hope you enjoy part one. There’s more coming in a few weeks.
Hear all our previous stories! armandalegshow...
Read the First Aid Kit newsletter, with our practical tips on surviving the health care system, financially: armandalegshow...
Our Twitter: @armandalegshow

[@AkmaralKulatayeva]

Very important and really unrecognized topic.Thanks for sharing